EDUCATION:

FACULTY APPOINTMENTS:

AWARDS AND OTHER PROFESSIONAL ACTIVITIES:
Member, Southwest Oncology Group (SWOG), Cytogenetics Study Group
Member, Children’s Oncology Group (COG), Cytogenetics
Basic Scientific Fellowship on the Cancer Chemotherapy Training Grant CA-09207, 1984
National Cancer Institute Postdoctoral Fellow. Biology of Cancer Training Grant, T-32 CA-09532, 1986-1988

PUBLICATION:
1. Visscher DW, Wallis T, Awussah S, Mohamed A, Crissman JD: Evaluation of c-myc and chromosome 8 copy number in breast carcinoma using Interphase cytogenetics. Genes, Chromosomes, Cancer, 18: 1-7, 1997. [Medline]

2. Mohamed AN, Zalupski MM, Ryan JR, Koppitch F, Balcerzak, Kempf R, Wolman S: Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma: A Southwest Oncology Group Study. Cancer Genet. Cytogenet 99:45-53, 1997. [Medline]

3. Chopra DP, Sarkar FH, Grignon DJ, Sakr WA, Mohamed AN, Waghrey A: Growth of human nondiploid primary prostate tumor epithelial cells in vitro. Cancer Res, 57:3688-3692, 1997. [Medline]

4. Al-Katib A, Smith AR, Kamanda WS, Petit GR, Hamdan M, Mohamed AN, Mohammad RM: Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts Clinical Cancer Res. 4: 1305-1314, 1998,[Medline]

5. Mohammad RM, Dugan MC, Mohamed AN, Almatchy VP, Flake TM, Dergham S, Shields T, Al-Katib AA, Vaitkevicius VK, Sarkar FH: Establishment of human pancreatic tumor xenograft Modal: Potential application for preclinical evaluation of novel therapeutic agents. Pancreas, 16:19-25, 1998. [Medline]

6. Savasan S/ Lorenzana A, Williams JA, Mohamed AN, Ravindranath Y, Zielenska MI Hamre MI Haas JE, Rector F, Sough H, Abel E: Constitutional balanced translations in alveolar rhabdomyosarcoma Cancer Genet. Cytogenet. 105: 50-54, 1998. [Medline]

7. Mohamed AN, Varterasian M, Dobin S, McConnell TS, Wolman SR, Willman CL, Rankin C, Head D, Slovak ML: Trisomy 6 as a primary karyotypic aberration in hematological disorders. Cancer Genet Cytogenet.106:152-155,1998. [Medline]

8. Savasan S, Fulgenzi LA, Rabah R, Mohamed AN, Ravindranath Y: Generalized infantile myofibromatosis in a patient with Turner syndrome: A trial of interferon alpha. J Pediatr l33: 694-696, 1998. [Medline]

9. Mohamed AN, El-Naggar M, Koppitch FC, Bakdounes KM, and Grignon DJ: Chromosome analysis of six chromophobe renal cell carcinomas. J Urologic. .Pathology 9: 223-231, 1999.

10. Adsay V, Dergharn ST, Koppitch FC, Dugan MC, Mohamed AN, Vaitkevicius V, Sarkar FH: Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma. Pancreas, 18:111-116, 1999. [Medline]

11. Virgin JB, Hurley PM, Nahhas F, Bebchuk KG, Mohamed AN, Sakr WA, Bright R, Cher ML: Isochromosme 8q formation is associated with 8p loss of heterozygosity in a prostate cancer cell line. Prostate 41:49-57, 1999. [Medline]

12. Mohammad RM, Li Y, Mohamed AN, Pet tit G, Adsay V, Vaitkevicius VK Al-Katib, Sarkar FH: Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma. Pancreas 19:353-361,
1999. [Medline]

13. Batanian JR, Slovak ML, Mohamed AN, Dobin S, Luthardt FW, Keitges EA, The South West Oncology Group Cytogenetics Committee: Trisomy 15 is frequently present as a minor clone in patient with hematological disorders and as a major clone in patients with AML. Cancer Genet Cytogenet 121:186-189, 2000. [Medline]

14. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil K, Mohamed AN, Paietta E, Willman CL, Head DR, Forman SJ, Appelbaum FR: Karyotypic analysis predicts outcome of pre-and post-remission therapy in adult acute myeloid leukemia (AML): a SWOG (S9034)/ECOG (E3489) intergroup study. Blood 96:4075-4083, 2000. [Medline]

15. Mohamed AN, Palutke M, Eisenberg L, Al-katib A: Chromosomal analyses of 52 cases of follicular lymphma with t(14;18); Including blastic/blastoid variant. Cancer Genet. Cytogenet 126:45-51, 2001. [Medline]

16. Santner S, Dawson P, Tait L, Soul H, Eliason J, Mohamed AN, Wolman SR, Heppner GH, Miller FR: Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 65:101-110, 2001. [Medline]

17. Mohamed AN, Ebrahim SA, Aatre A, Faisal Qureshi, Suzanne Jacques, Evans MI: Prenatal diagnosis of a de novo ring chromosome 11.Am J Med Genet 102: 368-371, 2001Vaishampyayan U, Mohamed AN, Dugan MC, Bloom R, Palutke M: Blastoid form of mantle cell lymphoma associated with Burkitt-like translocation. British J Hematol 115:66-68, 200118. Rakozy C, Mohamed AN, Vo T,. Khatib G, Long PM, Eilender D, Palutke M: CD56+/CD4+ Lymphomas and Leukemias are Morphologically and Clinically Diverse. AM J Clin Pathol. 116: 168-176, 2001.19. Bayerl M, Rakozy C, Mohamed AN, Vo TD, Long M, Eilender D, Palutke M: Blastic natural killer cell lymphoma/leukemia: A report of seven cases. I Am J Clinical Pathology 117:41-50, 2002.20. Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in sever combined immunodeficient mice bearing human t(14;18) follicular lymphoma. Clinical Cancer Res. 8:1277-1283, 2002 [Medline]

18. Rakozy C, Mohamed AN, Vo T,. Khatib G, Long PM, Eilender D, Palutke M: CD56+/CD4+ Lymphomas and Leukemias are Morphologically and Clinically Diverse. AM J Clin Pathol. 116: 168-176, 2001.19. Bayerl M, Rakozy C, Mohamed AN, Vo TD, Long M, Eilender D, Palutke M: Blastic natural killer cell lymphoma/leukemia: A report of seven cases. I Am J Clinical Pathology 117:41-50, 2002.20. Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in sever combined immunodeficient mice bearing human t(14;18) follicular lymphoma. Clinical Cancer Res. 8:1277-1283, 2002 [Medline]

19. Bayerl M, Rakozy C, Mohamed AN, Vo TD, Long M, Eilender D, Palutke M: Blastic natural killer cell lymphoma/leukemia: A report of seven cases. I Am J Clinical Pathology 117:41-50, 2002.20. Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in sever combined immunodeficient mice bearing human t(14;18) follicular lymphoma. Clinical Cancer Res. 8:1277-1283, 2002 [Medline]

20. Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in sever combined immunodeficient mice bearing human t(14;18) follicular lymphoma. Clinical Cancer Res. 8:1277-1283, 2002 [Medline]